Creating a virtual support group in an interactive narrative:a companionship game for cancer patients

Over one in five cancer patients are affected by feelings of loneliness [1]. This paper proposes a text-based game aimed at affected cancer patients, in which the player develops relationships with non-player characters in the context of a fictitious cancer support group. This would be designed with the aim of alleviating patient loneliness and fostering a sense of companionship. This work is part of an interdisciplinary project led by Abertay University and partnered with Macmillan Cancer Support, exploring the ways in which interactive storytelling can be used to support cancer patients. The game’s narrative and characters will be designed drawing on real patient experiences gathered in interviews. The game will go through several iterations of feedback and rewriting in response to focus groups held with patients and healthcare professionals.</p

Towards reusable personas for everyday design

Personas are artificial character based representations of user goals, attitudes, motivations and abilities which enable designers to focus their design efforts on key, targeted users. The success of personas in design is due to their capacity to enable designers to empathize with users and understand user goals. Persona development is rooted in the rigorous collection and analysis of data specifically related to the design project being undertaken. New design projects thus require the development of new personas. Since redevelopment is not always achievable attention has turned towards reuse of personas and the underlying data. This paper reports on ongoing research into the development of reusable personas for use by non-expert, everyday designers. Such designers are regularly faced with small scale but diverse design challenges for which they cannot carry out user research and modelling. They can, however, make use of general, reusable personas developed independently of their current design project

Screening and characterization of antimicrobial secondary metabolites from Halomonas salifodinae MPM-TC and its in vivo antiviral influence on Indian white shrimp Fenneropenaeus indicus against WSSV challenge

AbstractAntimicrobial secondary metabolites from extremophiles play a significant role in the pharmacological industry due to their stable and strong activity and it is used in the treatment of microbial infections. In the present work, Halomonas salifodinae MPM-TC (M. Peter Marian-T. Citarasu) was isolated from the solar salt works in India and identified by 16S rRNA sequencing. The secondary metabolites were extracted from H. salifodinae MPM-TC and tested for antibacterial activity against aquatic bacterial pathogens such as Vibrio harveyi, Vibrio parahaemolyticus, Pseudomonas aeruginosa and Aeromonas hydrophila isolated from infected fish/shrimp, and it effectively controlled them with more than 10mm of zone of inhibition. The metabolites were purified through silica column chromatography and in vitro antiviral activity was performed against White Spot Syndrome Virus (WSSV) using different fractions. Among the different tested fractions, fraction-III (F-III) was able to suppress WSSV replication. Shrimps challenged with a WSSV inoculum incubated with F-III and treated Fenneropenaeus indicus survived around twice as many as the controls. Gas chromatography–mass spectroscopic (GC–MS) analysis revealed that the antiviral active fraction contains around eight compounds including Perfluorotributylamine, Cyclopentane, 1-butyl-2-ethyl and 1,1′-Biphenyl]-3-amine. Further the active fraction F-III was incorporated in the artificial diets at the concentration of 200 (HS1), 400 (HS2) and 800 (HS3) μgkg−1 and fed to F. indicus for 30days. After 30days of culture, shrimps were challenged with virulent WSSV and studied for WSSV VP 28 gene expression, biochemical, haematological and immunological changes. Surprisingly, groups treated with lower concentrations of fraction F-III (HS1 or HS2) significantly (P<0.05) suppressed the viral replication. Different levels of protein and glucose, improved total haemocyte count (THC), coagulase activity and oxyhaemocyanin level all were comparable to controls. Also, immunological parameters such as prophenol oxidase and intracellular superoxide anion production were significantly increased (F=97.18; P⩽0.001 and F=5.70; P⩽0.05) in the groups treated with the three test concentrations. The presence of antiviral and immunostimulant active principles in the F-III fraction effectively suppressed the WSSV load and boosted F. indicus’s immune system. This research will help to develop novel antiviral drugs from plants against aquatic important pathogens

Human factors for dementia: Evidence based design

Designing care environments for people living with dementia is a complex challenge as the key stakeholder may have difficulty communicating their capabilities, limitations and preferences. This paper describes the use of evidence-based design personas in a multi-disciplinary team with architects and chartered human factors specialists. Four individual personas (Alison, Barry, Christine and David) and a couple persona (Chris and Sally) were used to bring the voices of the people living with different stages of dementia to the design process. Their changing/fluctuating symptoms were communicated in two formats (wheel and matrix) within an inclusive design process to adapt a Victorian semi-detached house. The demonstrator house presents evidence based design, adaptation and support solutions to support people living with dementia to age well at home

The effects of unbleached and bleached nanocellulose on the thermal and flammability of plypropylene-reinforced kenaf core hybrid polymer bionanocomposites

The thermal, thermo-mechanical and flammability properties of kenaf core hybrid polymer nanocomposites reinforced with unbleached and bleached nanocrystalline cellulose (NCC) were studied. The studied chemical composition found that unbleached NCC (NCC-UB) had 90% more lignin content compared to bleached NCC (NCC-B). Nanocelluloses were incorporated within polypropylene (PP) as the matrix, together with kenaf core as a main reinforcement and maleic anhydride grafted polypropylene (MAPP) as a coupling agent via a melt mixing compounding process. The result showed that the thermal stability of the nanocomposites was generally affected by the presence of lignin in NCC-UB and sulfate group on the surface of NCC-B. The residual lignin in NCC-UB appeared to overcome the poor thermal stability of the composites that was caused by sulfation during the hydrolysis process. The lignin helped to promote the late degradation of the nanocomposites, with the melting temperature occurring at a relatively higher temperature of 219.1 °C for PP/NCC-UB, compared to 185.9 °C for PP/NCC-B. Between the two types of nanocomposites, PP/NCC-B had notably lower thermo-mechanical properties, which can be attributed to the poor bonding and dispersion properties of the NCC-B in the nanocomposites blend. The PP/NCC-UB showed better thermal properties due to the effect of residual lignin, which acted as a compatibilizer between NCC-UB and polymer matrix, thus improved the bonding properties. The residual lignin in PP/NCC-UB helped to promote char formation and slowed down the burning process, thus increasing the flame resistance of the nanocomposites. Overall, the residual lignin on the surface of NCC-UB appeared to aid better stability on the thermal and flammability properties of the nanocomposites

The effects of unbleached and bleached nanocellulose on the thermal and flammability of polypropylene-reinforced kenaf core hybrid polymer bionanocomposites

The thermal, thermo-mechanical and flammability properties of kenaf core hybrid polymer nanocomposites reinforced with unbleached and bleached nanocrystalline cellulose (NCC) were studied. The studied chemical composition found that unbleached NCC (NCC-UB) had 90% more lignin content compared to bleached NCC (NCC-B). Nanocelluloses were incorporated within polypropy-lene (PP) as the matrix, together with kenaf core as a main reinforcement and maleic anhydride grafted polypropylene (MAPP) as a coupling agent via a melt mixing compounding process. The result showed that the thermal stability of the nanocomposites was generally affected by the presence of lignin in NCC-UB and sulfate group on the surface of NCC-B. The residual lignin in NCC-UB appeared to overcome the poor thermal stability of the composites that was caused by sulfation during the hydrolysis process. The lignin helped to promote the late degradation of the nanocom-posites, with the melting temperature occurring at a relatively higher temperature of 219.1? C for PP/NCC-UB, compared to 185.9? C for PP/NCC-B. Between the two types of nanocomposites, PP/NCC-B had notably lower thermo-mechanical properties, which can be attributed to the poor bonding and dispersion properties of the NCC-B in the nanocomposites blend. The PP/NCC-UB showed better thermal properties due to the effect of residual lignin, which acted as a compatibilizer between NCC-UB and polymer matrix, thus improved the bonding properties. The residual lignin in PP/NCC-UB helped to promote char formation and slowed down the burning process, thus increasing the flame resistance of the nanocomposites. Overall, the residual lignin on the surface of NCC-UB appeared to aid better stability on the thermal and flammability properties of the nanocomposites

Does the aldosterone: renin ratio predict the efficacy of spironolactone over bendroflumethiazide in hypertension? A clinical trial protocol for RENALDO (RENin-ALDOsterone) study

&lt;p&gt;Background: High blood pressure is an important determinant of cardiovascular disease risk. Treated hypertensives do not attain a risk level equivalent to normotensives. This may be a consequence of suboptimal blood pressure control to which indiscriminate use of antihypertensive drugs may contribute. Indeed the recent ALLHAT[1]study suggests that thiazides should be given first to virtually all hypertensives. Whether this is correct or whether different antihypertensive therapies should be targeted towards different patients is a major unresolved issue, which we address in this study.&lt;/p&gt; &lt;p&gt;The measurement of the ratio of aldosterone: renin is used to identify hypertensive subjects who may respond well to treatment with the aldosterone antagonist spironolactone. It is not known if subjects with a high ratio have aldosteronism or aldosterone-sensitive hypertension is debated but it is important to know whether spironolactone is superior to other diuretics such as bendroflumethiazide in this setting.&lt;/p&gt; &lt;p&gt;Methods/design: The study is a double-blind, randomised, crossover, controlled trial that will randomise 120 hypertensive subjects to 12 weeks treatment with spironolactone 50 mg once daily and 12 weeks treatment with bendroflumethiazide 2.5 mg once daily. The 2 treatment periods are separated by a 2-week washout period. Randomisation is stratified by aldosterone: renin ratio to include equal numbers of subjects with high and low aldosterone: renin ratios.&lt;/p&gt; &lt;p&gt;Primary Objective – To test the hypothesis that the aldosterone: renin ratio predicts the antihypertensive response to spironolactone, specifically that the effect of spironolactone 50 mg is greater than that of bendroflumethiazide 2.5 mg in hypertensive subjects with high aldosterone: renin ratios.&lt;/p&gt; &lt;p&gt;Secondary Objectives – To determine whether bendroflumethiazide induces adverse metabolic abnormalities, especially in subjects with high aldosterone: renin ratios and if baseline renin measurement predicts the antihypertensive response to spironolactone and/or bendrofluazide.&lt;/p&gt; &lt;p&gt;Discussion: The numerous deleterious effects of hypertension dictate the need for a systematic approach for its treatment. In spite of various therapies, resistant hypertension is widely prevalent. Among various factors, primary aldosteronism is an important cause of resistant hypertension and is now more commonly recognised. More significantly, hypertensives with primary aldosteronism are also exposed to various other deleterious effects of excess aldosterone. Hence treating hypertension with specific aldosterone antagonists may be a better approach in this group of patients. It may lead on to better blood pressures with fewer medications.&lt;/p&gt